Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe-Marc Chauvin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal for Immunotherapy of Cancer|September 9, 2020
TIGIT in cancer immunotherapyJoe-Marc Chauvin, Hassane M Zarour
Seminars in Immunology|December 8, 2020
Targeting novel inhibitory receptors in cancer immunotherapyQuan-Quan Ding, Joe-Marc Chauvin, Hassane M Zarour
Cancer Research|February 28, 2015
IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T CellsZhaojun Sun, Julien Fourcade, Ornella Pagliano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2009
Reduced frequency of regulatory T cells in peripheral blood stem cell compared to bone marrow transplantationsCéline Blache, Joe-Marc Chauvin, Aude Marie-Cardine, et al.
Plos Biology|April 10, 2014
CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel diseaseGuillaume Sarrabayrouse, Céline Bossard, Joe-Marc Chauvin, et al.
The Journal of Clinical Investigation|April 14, 2015
TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patientsJoe-Marc Chauvin, Ornella Pagliano, Julien Fourcade, et al.
JCI Insight|July 27, 2018
CD226 opposes TIGIT to disrupt Tregs in melanomaJulien Fourcade, Zhaojun Sun, Joe-Marc Chauvin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in MelanomaJoe-Marc Chauvin, Mignane Ka, Ornella Pagliano, et al.
Cancer Research|December 18, 2013
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccinesJulien Fourcade, Zhaojun Sun, Ornella Pagliano, et al.
Cancer Immunology Research|June 27, 2019
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor CellLulu Shao, Weizhou Hou, Nicole E Scharping, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal for Immunotherapy of Cancer|September 9, 2020
TIGIT in cancer immunotherapyJoe-Marc Chauvin, Hassane M Zarour
Seminars in Immunology|December 8, 2020
Targeting novel inhibitory receptors in cancer immunotherapyQuan-Quan Ding, Joe-Marc Chauvin, Hassane M Zarour
Cancer Research|February 28, 2015
IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T CellsZhaojun Sun, Julien Fourcade, Ornella Pagliano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2009
Reduced frequency of regulatory T cells in peripheral blood stem cell compared to bone marrow transplantationsCéline Blache, Joe-Marc Chauvin, Aude Marie-Cardine, et al.
Plos Biology|April 10, 2014
CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel diseaseGuillaume Sarrabayrouse, Céline Bossard, Joe-Marc Chauvin, et al.
The Journal of Clinical Investigation|April 14, 2015
TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patientsJoe-Marc Chauvin, Ornella Pagliano, Julien Fourcade, et al.
JCI Insight|July 27, 2018
CD226 opposes TIGIT to disrupt Tregs in melanomaJulien Fourcade, Zhaojun Sun, Joe-Marc Chauvin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in MelanomaJoe-Marc Chauvin, Mignane Ka, Ornella Pagliano, et al.
Cancer Research|December 18, 2013
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccinesJulien Fourcade, Zhaojun Sun, Ornella Pagliano, et al.
Cancer Immunology Research|June 27, 2019
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor CellLulu Shao, Weizhou Hou, Nicole E Scharping, et al.
Pageof 2